← Back to Clinical Trials
Recruiting NCT07224204
Life at 100.4: An Immersive Social Virtual Reality (VR) Education Tool for Adolescent and Young Adult Cancer Patients and Caregivers
Trial Parameters
Condition Cancer
Sponsor Yale University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 45
Sex ALL
Min Age 13 Years
Max Age 39 Years
Start Date 2026-02-11
Completion 2027-04
All Conditions
Interventions
Life at 100.4
Brief Summary
The purpose of this study is to design and Beta test the Life at 100.4, an immersive social virtual reality education tool, with an anticipated 5 patient-caregiver-provider triads.Patients at Yale Pediatric Hematology and Oncology with a new oncologic diagnosis and their caregivers will be eligible for enrollment. Investigators will determine the feasibility and acceptability of implementing Life at 100.4 using validated measures.
Eligibility Criteria
Inclusion Criteria: * Newly diagnosed with a malignancy or bone marrow failure condition * Planned to receive chemotherapy and receive a central line Exclusion Criteria: * Medical contraindication to virtual reality including head wounds and history of seizure with flashing lights * No plan to receive chemotherapy